Related Experiment Video
Updated: Sep 15, 2026

Creation of Reversible Cholestatic Rat Model
Published on: May 21, 2011
Update on the etiologies and management of neonatal cholestasis
1Department of Pediatrics, Texas Children's Liver Center, Baylor College of Medicine, Houston, Texas, USA. skarpen@bcm.tmc.edu
Insights
Early detection of neonatal cholestasis in jaundiced infants is crucial for timely intervention. Elevated conjugated bilirubin levels in infants warrant a comprehensive work-up for liver disease, improving patient outcomes.
Area of Science:
- Pediatrics
- Neonatology
- Hepatology
Background:
- Neonatal cholestasis presents a diagnostic challenge for pediatricians.
- Early identification of liver disease in infants is critical for managing serious, life-threatening conditions.
- Cholestasis is a key sign in several neonatal liver diseases.
Purpose of the Study:
- To emphasize the importance of early detection and work-up for neonatal cholestasis.
- To highlight the role of serum conjugated bilirubin levels in initiating diagnostic evaluation.
- To underscore the implications of newly identified genetic and infectious causes.
Main Methods:
- Measurement of serum conjugated bilirubin levels.
- Clinical evaluation of jaundiced infants presenting within the first month of life.
- Initiation of a work-up to determine the cause of neonatal cholestasis.
Main Results:
- Elevated conjugated bilirubin levels necessitate further investigation.
- Jaundice persisting beyond two weeks or appearing within the first month indicates a need for work-up.
- Emerging genetic and infectious etiologies are influencing diagnostic and management strategies.
Conclusions:
- Prompt recognition and evaluation of neonatal cholestasis are essential.
- Serum conjugated bilirubin is a key biomarker for initiating diagnostic processes.
- Understanding the genetic and infectious causes of neonatal cholestasis improves infant care.
Abstract:
The early detection of cholestatic liver disease is one of the major challenges facing pediatricians when evaluating the jaundiced infant. Early recognition of liver disease greatly facilitates the care and outcome of infants, because several serious life-threatening disorders may have cholestasis as a major presenting sign of underlying neonatal liver disease. A key component of the work-up is measurement of serum conjugated bilirubin levels, which if elevated should prompt the clinician to initiate a work-up to determine the cause of neonatal cholestasis. In general, if a patient is developing progressive jaundice soon after birth, is still jaundiced at 2 weeks of life, or develops jaundice within the first month of life, a work-up for neonatal cholestasis should begin. A number of previously undiagnosed causes of neonatal cholestasis are beginning to be assigned genetic and infectious etiologies, with significant implications for the work-up and management of cholestatic infants.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Myocarditis IV: Nursing Management
Cholecystitis

